Experimental Models for the Assessment of Antiarrhythmic and Proarrhythmic Drug Action: Traditional and Newer Models

[1]  M. Lesh,et al.  Autonomic nervous system and sudden cardiac death. , 1996, Journal of the American College of Cardiology.

[2]  L. Chi,et al.  Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide. , 1993, Journal of Molecular and Cellular Cardiology.

[3]  B. Lucchesi,et al.  Protection Against Programmed Electrical Stimulation-Induced Ventricular Tachycardia and Sudden Cardiac Death by NE-10064, a Class III Antiarrhythmic Drug , 1993, Journal of cardiovascular pharmacology.

[4]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[5]  S. Ballin,et al.  AHA out front in fight to save animal research laboratories. , 1993, Circulation.

[6]  J R Roelandt,et al.  Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. , 1993, Circulation.

[7]  M. Legato.  The anatomic matrix as a factor in susceptibility to lethal arrhythmias in a canine model of sudden cardiac death. , 1993, Journal of molecular and cellular cardiology.

[8]  L. Chi,et al.  Antifibrillatory and Profibrillatory Actions of Selected Class I Antiarrhythmic Agents , 1993, Journal of cardiovascular pharmacology.

[9]  L. Chi,et al.  Actions of Pinacidil at a Reduced Potassium Concentration: A Direct Cardiac Effect Possibly Involving the ATP‐Dependent Potassium Channel , 1993, Journal of cardiovascular pharmacology.

[10]  A. Buxton.  Antiarrhythmic Drugs: Good for Premature Ventricular Complexes but Bad for Patients? , 1992, Annals of Internal Medicine.

[11]  A. Uprichard,et al.  Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death , 1991, Journal of cardiovascular pharmacology.

[12]  L. Chi,et al.  The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. , 1991, The Journal of pharmacology and experimental therapeutics.

[13]  S. Connolly,et al.  Post‐Myocardial Infarction Mortality in Patients With Ventricular Premature Depolarizations: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study , 1991, Circulation.

[14]  L. Chi,et al.  Electrophysiology and Antiarrhythmic Actions of E‐4031 in the Experimental Animal Model of Sudden Coronary Death , 1991, Journal of cardiovascular pharmacology.

[15]  L. Chi,et al.  Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death , 1990, Journal of cardiovascular pharmacology.

[16]  L. Chi,et al.  Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death , 1990, Journal of cardiovascular pharmacology.

[17]  J. Rozanski,et al.  Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction. , 1989, American heart journal.

[18]  L. Chi,et al.  Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing , 1989, Journal of cardiovascular pharmacology.

[19]  M. Sanguinetti,et al.  Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. , 1989, Journal of molecular and cellular cardiology.

[20]  B. Lucchesi,et al.  Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation. , 1989, International journal of cardiology.

[21]  L. Opie,et al.  Reduction in ischemic myocardial K+ efflux and arrhythmias by glibenclamide , 1988 .

[22]  J. K. Smallwood,et al.  Cardiac Electrophysiological Effects of Pinacidil and Related Pyridylcyanoguanidines: Relationship to Antihypertensive Activity , 1988, Journal of cardiovascular pharmacology.

[23]  M. Lazdunski,et al.  Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels. , 1988, The Journal of biological chemistry.

[24]  P. Wolf,et al.  Mechanism of Ventricular Vulnerability to Single Premature Stimuli in Open‐Chest Dogs , 1988, Circulation research.

[25]  J. Ruskin,et al.  Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction. , 1988, Journal of the American College of Cardiology.

[26]  P. Scanlon,et al.  Comparative Effects of Antiarrhythmic Drugs on the Ventricular Fibrillation Threshold , 1988, Journal of cardiovascular pharmacology.

[27]  S G Kim,et al.  The management of patients with life-threatening ventricular tachyarrhythmias: programmed stimulation or Holter monitoring (either or both)? , 1987, Circulation.

[28]  B. Lucchesi,et al.  Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin. , 1987, Journal of cardiovascular pharmacology.

[29]  B. Lucchesi,et al.  Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[30]  B. MacLeod,et al.  Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. , 1987, Journal of molecular and cellular cardiology.

[31]  宏暢 高橋,et al.  Sodium 5-hydroxydecanoateの実験的虚血性心室性不整脈への効果とその作用機序に関する検討 , 1987 .

[32]  W. Kou,et al.  Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. , 1987, Journal of the American College of Cardiology.

[33]  Lucchesi Br,et al.  Preclinical assessment of antiarrhythmic drugs. , 1986 .

[34]  Y. Vedernikov.  Mechanisms of coronary spasm of isolated human epicardial coronary segments excised 3 to 5 hours after sudden death. , 1986, Journal of the American College of Cardiology.

[35]  W. Roberts.  Sudden cardiac death: definitions and causes. , 1986, The American journal of cardiology.

[36]  J. Hammon,et al.  Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death. , 1986, Circulation.

[37]  B. Singh,et al.  Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1986, American heart journal.

[38]  S. Factor,et al.  Smooth muscle contraction bands in the media of coronary arteries: a postmortem marker of antemortem coronary spasm? , 1985, Journal of the American College of Cardiology.

[39]  H. Saner,et al.  The disease-free wall in coronary atherosclerosis: its relation to degree of obstruction. , 1985, Journal of the American College of Cardiology.

[40]  B. Waller,et al.  Coronary luminal shape and the arc of disease-free wall: morphologic observations and clinical relevance. , 1985, Journal of the American College of Cardiology.

[41]  L. Griffith,et al.  Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. , 1985, The American journal of cardiology.

[42]  B. Lucchesi,et al.  Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs. , 1985, The Journal of pharmacology and experimental therapeutics.

[43]  B. Lucchesi,et al.  Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. , 1985, American heart journal.

[44]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[45]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. , 1984, The Journal of pharmacology and experimental therapeutics.

[46]  N. El-Sherif,et al.  Reentrant ventricular arrhythmias in the late myocardial infarction period. II. Burst pacing versus multiple premature stimulation in the induction of reentry. , 1984, Journal of the American College of Cardiology.

[47]  A. Jaffe,et al.  Risk factors for sudden death after acute myocardial infarction: two-year follow-up. , 1984, The American journal of cardiology.

[48]  M. Josephson,et al.  Cardiac arrest recorded on ambulatory electrocardiograms. , 1984, The American journal of cardiology.

[49]  J. M. Zimmerman,et al.  Antidysrhythmic actions of meobentine sulfate. , 1984, American heart journal.

[50]  B. Lucchesi,et al.  Development of Ventricular Tachyarrhythmias in the Conscious Canine During the Recovery Phase of Experimental Ischemic Injury: Effect of Bethanidine Administration , 1984, Journal of cardiovascular pharmacology.

[51]  H. L. Stone,et al.  Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.

[52]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[53]  J. Bigger,et al.  Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction. , 1984, The American journal of cardiology.

[54]  M. Josephson,et al.  Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. , 1983, The American journal of cardiology.

[55]  J. Mason,et al.  Nature of inducible ventricular tachyarrhythmias in a canine chronic myocardial infarction model. , 1983, The American journal of cardiology.

[56]  B. Lucchesi,et al.  Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. , 1983, Circulation.

[57]  C. Furberg.  Effect of antiarrhythmic drugs on mortality after myocardial infarction. , 1983, The American journal of cardiology.

[58]  A. Noma,et al.  ATP-regulated K+ channels in cardiac muscle , 1983, Nature.

[59]  B. Lucchesi,et al.  Antifibrillatory Actions of d, l‐Nadolol in a Conscious Canine Model of Sudden Coronary Death , 1983, Journal of cardiovascular pharmacology.

[60]  G. Specchia,et al.  Ventricular tachyarrhythmias in Prinzmetal's variant angina: clinical significance and relation to the degree and time course of S-T segment elevation. , 1983, The American journal of cardiology.

[61]  B. Lucchesi,et al.  Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. , 1983, American heart journal.

[62]  B. Lucchesi,et al.  Effects of diltiazem upon experimental ventricular dysrhythmias. , 1983, The Journal of pharmacology and experimental therapeutics.

[63]  J. Anderson,et al.  Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. , 1983, The American journal of cardiology.

[64]  S. Yusuf,et al.  Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. , 1983, British medical journal.

[65]  B. Lucchesi,et al.  Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. , 1982, The American journal of cardiology.

[66]  J. Kjekshus,et al.  Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[67]  H. L. Stone,et al.  Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death , 1982, Circulation.

[68]  D. Waters,et al.  Clinical Characteristics Associated with Sudden Death in Patients with Variant Angina , 1982, Circulation.

[69]  A. Maseri,et al.  ROLE OF CORONARY ARTERIAL SPASM IN SUDDEN CORONARY ISCHEMIC DEATH , 1982, Annals of the New York Academy of Sciences.

[70]  J. K. Gibson,et al.  Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate. , 1981, The Journal of pharmacology and experimental therapeutics.

[71]  R. Campbell,et al.  ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[72]  H. L. Stone,et al.  Left Stellectomy in the Prevention of Ventricular Fibrillation Caused by Acute Myocardial Ischemia in Conscious Dogs with Anterior Myocardial Infarction , 1980, Circulation.

[73]  P. Macfarlane,et al.  A prospective randomized trial of tocainide in patients following myocardial infarction. , 1980, American heart journal.

[74]  A Malliani,et al.  Neural mechanisms in life-threatening arrhythmias. , 1980, American heart journal.

[75]  B. Pitt,et al.  Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations. , 1980, The American journal of cardiology.

[76]  B. Bulkley,et al.  Ischemia at a Distance After Acute Myocardial Infarction: A Cause of Early Postinfarction Angina , 1980, Circulation.

[77]  D. Euler.  Norepinephrine release by ventricular stimulation: effect on fibrillation thresholds. , 1980, The American journal of physiology.

[78]  H. Karagueuzian,et al.  Protracted ventricular tachcardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. , 1979, Circulation research.

[79]  L. Horowitz,et al.  Recurrent Sustained Ventricular Tachycardia: 4. Pleomorphism , 1979, Circulation.

[80]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[81]  R Lazzara,et al.  Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. , 1978, Circulation research.

[82]  R Lazzara,et al.  Re‐entrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 1. Conduction Characteristics in the Infarction Zone , 1977, Circulation.

[83]  W. Weaver,et al.  Angiographic findigs and prognostic indicators in patients resuscitated from sudden cardiac death. , 1976, Circulation.

[84]  R. Verrier,et al.  Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release. , 1975, The American journal of cardiology.

[85]  F. Copp,et al.  Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts. , 1975, The Journal of pharmacology and experimental therapeutics.

[86]  J. Spear,et al.  Ventricular fibrillation threshold; its physiological and pharmacological importance. , 1975, Archives of internal medicine.

[87]  L. Cobb,et al.  Survival after Resuscitation from Out‐of‐Hospital Ventricular Fibrillation , 1974, Circulation.

[88]  Jørgen W. Herem.  Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. , 1974 .

[89]  J. Marshall,et al.  Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. , 1973, Cardiology.

[90]  A Malliani,et al.  A Cardiocardiac Sympathovagal Reflex in the Cat , 1973, Circulation research.

[91]  H. Wellens,et al.  Electrical Stimulation of the Heart in Patients with Ventricular Tachycardia , 1972, Circulation.

[92]  L. Kuller,et al.  Epidemiology of sudden death. , 1972, Archives of internal medicine.

[93]  W. Kannel,et al.  Premature mortality from coronary heart disease. The Framingham study. , 1971, JAMA.

[94]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[95]  R. Charlier.  Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors , 1970, British journal of pharmacology.

[96]  J. Papp,et al.  The effect of altered thyroid state on atrial intracellular potentials , 1970, The Journal of physiology.

[97]  J. Han,et al.  Ventricular vulnerability during acute coronary occlusion. , 1969, The American journal of cardiology.

[98]  D C Harrison,et al.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. , 1967, The New England journal of medicine.

[99]  L. Maclean,et al.  Ventricular fibrillation threshold. , 1961, The American journal of physiology.

[100]  H. Maling,et al.  Ventricular Arrhythmias Induced by Sympathomimetic Amines in Unanesthetized Dogs Following Coronary Artery Occlusion , 1957, Circulation research.

[101]  Carl J. Wiggers,et al.  VENTRICULAR FIBRILLATION DUE TO SINGLE, LOCALIZED INDUCTION AND CONDENSER SHOCKS APPLIED DURING THE VULNERABLE PHASE OF VENTRICULAR SYSTOLE , 1940 .

[102]  E. Cowles Andrus,et al.  THE REFRACTORY PERIOD OF THE NORMALLY-BEATING DOG'S AURICLE; WITH A NOTE ON THE OCCURRENCE OF AURICULAR FIBRILLATION FOLLOWING A SINGLE STIMULUS , 1930, The Journal of experimental medicine.

[103]  A. Castellanos,et al.  Sudden cardiac death. Structure, function, and time-dependence of risk. , 1992, Circulation.

[104]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[105]  P. Schwartz,et al.  Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. , 1992, Circulation.

[106]  M. Janse,et al.  Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction. , 1992, Circulation.

[107]  J. Ruskin.  Role of invasive electrophysiological testing in the evaluation and treatment of patients at high risk for sudden cardiac death. , 1992, Circulation.

[108]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[109]  D. Hearse,et al.  Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. , 1989, Journal of molecular and cellular cardiology.

[110]  L. DiCarlo,et al.  Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. , 1987, Pharmacology.

[111]  E. Prystowsky,et al.  Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. , 1986, The American journal of cardiology.

[112]  Johan Herlitz,et al.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.

[113]  B. Lucchesi,et al.  Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. , 1985, American heart journal.

[114]  José Jalife,et al.  Cardiac electrophysiology and arrhythmias , 1985 .

[115]  B. Lucchesi,et al.  Clinical pharmacology of antiarrhythmic therapy , 1984 .

[116]  A. Camm,et al.  Drugs with a class III antiarrhythmic action. , 1982, Pharmacology & therapeutics.

[117]  D L DeMets,et al.  Secondary prevention after myocardial infarction: a review of long-term trials. , 1982, Progress in cardiovascular diseases.

[118]  D. Reichenbach,et al.  Pathology of the heart in sudden cardiac death. , 1977, The American journal of cardiology.

[119]  E. E. Suckling,et al.  EXCITABILITY OF THE HEART , 1957 .